THE 2-MINUTE RULE FOR ABBV-744 IN THE TREATMENT OF DRUG-RESISTANT CANCERS

In Section A, individuals will receive various doses and schedules of oral ABBV-744 pill to recognize Protected dosing regimen. Supplemental members will likely be enrolled with the identified monotherapy dosign program. In Section B, participants will acquire oral ruxolitinib and ABBV-744 might be specified as "insert-on" therapy. In Segment C, me